According to the results of a prospective study (NCT00310180), 93.8% of lymph node negative, ER positive, and HER2 negative breast cancer patients with low Oncotype DX relapse scores were free of disease progression after 5 years follow-up [57]. The gene discussed is ERBB2; the disease is breast carcinoma.